Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/CALLIDITAS-THERAPEUTICS-A-44458575/noticia/El-f-rmaco-de-Travere-para-una-rara-afecci-n-renal-recomendado-para-su-aprobaci-n-en-la-UE-46016477/?utm_source=whatsapp&utm_medium=social&utm_campaign=share